Deuterium isotope effects on toluene metabolism. Product release as a rate-limiting step in cytochrome P-450 catalysis

https://doi.org/10.1016/0006-291X(89)92511-4Get rights and content

Abstract

Liver microsomes from phenobarbital-induced rats oxidize toluene to a mixture of benzyl alcohol plus o-, m- and p-cresol (ca. 69:31). Stepwise deuteration of the methyl group causes stepwise decreases in the yield of benzyl alcohol relative to cresols (ca. 24:76 for toluene-d3). For benzyl alcohol formation from toluene-d3DV = 1.92 and D(V/K)= 3.53. Surprisingly, however, stepwise deuteration induces stepwise increases in total oxidation, giving rise to an inverse isotope effect overall (DV = 0.67 for toluene-d 3). Throughout the series (i.e. d0, d1, d2, d3) the ratios of cresol isomers remain constant. These results are interpreted in terms of product release for benzyl alcohol being slower than release of cresols (or their epoxide precursors), and slow enough to be partially rate-limiting in turnover. Thus metabolic switching to cresol formation causes a net acceleration of turnover.

References (15)

  • IchinoseR. et al.

    Biochem. Pharmacol.

    (1987)
  • WhiteR.E. et al.

    Arch. Biochem. Biophys.

    (1984)
  • WaxmanD.J. et al.

    J. Biol. Chem.

    (1982)
  • WhiteR.E. et al.

    Arch. Biochem. Biophys.

    (1986)
  • CartoniG.P. et al.

    J. Chromatog.

    (1976)
  • HanzlikR.P. et al.

    Biochemistry

    (1984)
  • HanzlikR.P. et al.

    J. Am. Chem. Soc.

    (1985)
There are more references available in the full text version of this article.

Cited by (49)

  • Cytochrome P450 Enzymes

    2018, Comprehensive Toxicology: Third Edition
  • A Decade of Deuteration in Medicinal Chemistry

    2017, Annual Reports in Medicinal Chemistry
    Citation Excerpt :

    Additionally, as the system increases in complexity (Supersomes™ to microsomes to hepatocytes, etc.), other non-CYP clearance mechanisms may predominate and blunt the observed DIE. Furthermore, reducing CYP metabolism with deuterium at a known site of metabolism can “switch” metabolism to another site, resulting in no observed DIE (no change in clearance) or even an inverse DIE (faster clearance).14–16 For example, maraviroc (3, Fig. 2) is a negative allosteric modulator of the chemokine receptor CCR5 marketed as Selzentry® for the treatment of human immunodeficiency virus infections.

  • Deuterium in Drug Discovery and Development

    2011, Annual Reports in Medicinal Chemistry
    Citation Excerpt :

    In practice, the observed DIE, (kH/kD)obs for a metabolic reaction is often “masked”, which means that it is smaller than kH/kD or, in some cases, entirely absent [14]. There are also literature examples of inverse DIEs in which (kH/kD)obs < 1 [15]. A very large number of studies have appeared in the literature over the years reporting DIEs for a great many enzyme-catalyzed reactions.

  • Cytochrome P450 Enzymes

    2010, Comprehensive Toxicology, Second Edition
View all citing articles on Scopus
View full text